In terms of market side, this report researches the Rare Disease Genetic Testing revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

The global Rare Disease Genetic Testing market size in 2023 is 1039.3 million US dollars, and it is expected to be 2460.3 million US dollars by 2030, with a compound annual growth rate of 13.1% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Rare Disease Genetic Testing market include Quest Diagnostics Inc., Centogene N. V, Invitae Corp, 3billion, Inc., and Arup Laboratories. The share of the top 3 players in the Rare Disease Genetic Testing market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Rare Disease Genetic Testing market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Molecular Genetic Tests accounted for XX% of Rare Disease Genetic Testing market in 2023. Chromosomal Genetic Tests share of XX%.
Research Laboratories & CROs accounted for XX% of the Rare Disease Genetic Testing market in 2023. Hospitals & Clinics accounts for XX%.

Report Includes:
This report presents an overview of global market for Rare Disease Genetic Testing . Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key players of Rare Disease Genetic Testing , also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Rare Disease Genetic Testing , and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rare Disease Genetic Testing market share and industry ranking of main players, data from 2019 to 2024. Identification of the major stakeholders in the global Rare Disease Genetic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2019 to 2030. Evaluation and forecast the market size for Rare Disease Genetic Testing sales, projected growth trends, technology, application and end-user industry.

Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.
Chapter 2: Analysis of the competitive environment of Rare Disease Genetic Testing market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapters 3-5: Segmented the global Rare Disease Genetic Testing market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 6: Analyzes the main companies in the Rare Disease Genetic Testing industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 7: Analyzes the Rare Disease Genetic Testing business cost, including industrial chain and the proportion of business cost structure.
Chapter 8: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 9-10: Provide detailed Rare Disease Genetic Testing market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 11: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico

Player list
Quest Diagnostics Inc.
Centogene N. V
Invitae Corp
3billion, Inc.
Arup Laboratories
Eurofins Scientific
Strand Life Sciences
Ambry Genetics
Perkin Elmer, Inc.
Realm IDX, Inc.
Macrogen, Inc.

Types list
Molecular Genetic Tests
Chromosomal Genetic Tests
Biochemical Genetic Tests

Application list
Research Laboratories & CROs
Hospitals & Clinics
Diagnostic Laboratories

Table of Content

1 Rare Disease Genetic Testing Market Introduction and Overview
1.1 Rare Disease Genetic Testing Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Rare Disease Genetic Testing Revenue and Market Share by Manufacturer
2.2 Manufacturers Rare Disease Genetic Testing Production Sites, Area Served, Product Types
2.3 Rare Disease Genetic Testing Market Competitive Situation and Trends
2.3.1 Rare Disease Genetic Testing Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Global Rare Disease Genetic Testing Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Rare Disease Genetic Testing Market Share by Type 2019 VS 2023
3.2 Global Rare Disease Genetic Testing Revenue and Market Share by Type
4 Global Rare Disease Genetic Testing Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Rare Disease Genetic Testing Market Share by Application 2019 VS 2023
4.2 Global Rare Disease Genetic Testing Revenue Market Share by Application (2019-2024)
5 Global Market Growth Trends Analysis
5.1 Global Rare Disease Genetic Testing Market Size (2019-2024)
5.2 Rare Disease Genetic Testing Growth Trends Analysis by Regions
5.2.1 Rare Disease Genetic Testing Market Size by Regions: 2019 VS 2024 VS 2030
5.2.2 Rare Disease Genetic Testing Historic Revenue Market Size by Regions (2019-2024)
5.3 North America
5.3.1 North America Rare Disease Genetic Testing Revenue by Countries (2019-2024)
5.3.2 North America SWOT Analysis
5.3.3 United States
5.3.4 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Rare Disease Genetic Testing Revenue by Countries (2019-2024)
5.5.2 Asia Pacific SWOT Analysis
5.5.3 Japan
5.5.4 Korea
5.5.5 Southeast Asia
5.5.6 India
5.5.7 Australia
5.6 EMEA
5.6.1 EMEA Rare Disease Genetic Testing Revenue by Countries (2019-2024)
5.6.2 EMEA SWOT Analysis
5.6.3 Europe
5.6.4 Middle East
5.6.5 Africa
5.7 Latin America
5.7.1 Latin America Rare Disease Genetic Testing Revenue by Countries (2019-2024)
5.7.2 Latin America SWOT Analysis
5.7.3 Brazil
5.7.4 Argentina
5.7.5 Mexico
6 Players Profiles
6.1 Quest Diagnostics Inc.
6.1.1 Quest Diagnostics Inc. Company Profile
6.1.2 Rare Disease Genetic Testing Product Overview
6.1.3 Quest Diagnostics Inc. Rare Disease Genetic Testing Market Performance (2019-2024)
6.1.4 Quest Diagnostics Inc. Business Overview
6.1.5 SWOT Analysis
6.2 Centogene N. V
6.2.1 Centogene N. V Company Profile
6.2.2 Rare Disease Genetic Testing Product Overview
6.2.3 Centogene N. V Rare Disease Genetic Testing Market Performance (2019-2024)
6.2.4 Centogene N. V Business Overview
6.2.5 SWOT Analysis
6.3 Invitae Corp
6.3.1 Invitae Corp Company Profile
6.3.2 Rare Disease Genetic Testing Product Overview
6.3.3 Invitae Corp Rare Disease Genetic Testing Market Performance (2019-2024)
6.3.4 Invitae Corp Business Overview
6.3.5 SWOT Analysis
6.4 3billion, Inc.
6.4.1 3billion, Inc. Company Profile
6.4.2 Rare Disease Genetic Testing Product Overview
6.4.3 3billion, Inc. Rare Disease Genetic Testing Market Performance (2019-2024)
6.4.4 3billion, Inc. Business Overview
6.4.5 SWOT Analysis
6.5 Arup Laboratories
6.5.1 Arup Laboratories Company Profile
6.5.2 Rare Disease Genetic Testing Product Overview
6.5.3 Arup Laboratories Rare Disease Genetic Testing Market Performance (2019-2024)
6.5.4 Arup Laboratories Business Overview
6.5.5 SWOT Analysis
6.6 Eurofins Scientific
6.6.1 Eurofins Scientific Company Profile
6.6.2 Rare Disease Genetic Testing Product Overview
6.6.3 Eurofins Scientific Rare Disease Genetic Testing Market Performance (2019-2024)
6.6.4 Eurofins Scientific Business Overview
6.6.5 SWOT Analysis
6.7 Strand Life Sciences
6.7.1 Strand Life Sciences Company Profile
6.7.2 Rare Disease Genetic Testing Product Overview
6.7.3 Strand Life Sciences Rare Disease Genetic Testing Market Performance (2019-2024)
6.7.4 Strand Life Sciences Business Overview
6.7.5 SWOT Analysis
6.8 Ambry Genetics
6.8.1 Ambry Genetics Company Profile
6.8.2 Rare Disease Genetic Testing Product Overview
6.8.3 Ambry Genetics Rare Disease Genetic Testing Market Performance (2019-2024)
6.8.4 Ambry Genetics Business Overview
6.8.5 SWOT Analysis
6.9 Perkin Elmer, Inc.
6.9.1 Perkin Elmer, Inc. Company Profile
6.9.2 Rare Disease Genetic Testing Product Overview
6.9.3 Perkin Elmer, Inc. Rare Disease Genetic Testing Market Performance (2019-2024)
6.9.4 Perkin Elmer, Inc. Business Overview
6.9.5 SWOT Analysis
6.10 Realm IDX, Inc.
6.10.1 Realm IDX, Inc. Company Profile
6.10.2 Rare Disease Genetic Testing Product Overview
6.10.3 Realm IDX, Inc. Rare Disease Genetic Testing Market Performance (2019-2024)
6.10.4 Realm IDX, Inc. Business Overview
6.10.5 SWOT Analysis
6.11 Macrogen, Inc.
6.11.1 Macrogen, Inc. Company Profile
6.11.2 Rare Disease Genetic Testing Product Overview
6.11.3 Macrogen, Inc. Rare Disease Genetic Testing Market Performance (2019-2024)
6.11.4 Macrogen, Inc. Business Overview
6.11.5 SWOT Analysis
7 Rare Disease Genetic Testing Business Cost Analysis
7.1 Labor Cost Analysis
7.2 Proportion of Manufacturing Cost Structure
7.3 Rare Disease Genetic Testing Industrial Chain Analysis
8 Rare Disease Genetic Testing Industry Dynamic Analysis
8.1 Rare Disease Genetic Testing Market Trends Analysis
8.2 Rare Disease Genetic Testing Market Drivers Analysis
8.3 Rare Disease Genetic Testing Market Challenges Analysis
8.4 Rare Disease Genetic Testing Market Restraints Analysis
9 Global Rare Disease Genetic Testing Forecast Market Analysis by Type & Application
9.1 Global Rare Disease Genetic Testing Revenue Market Forecast by Type (2024-2030)
9.2 Rare Disease Genetic Testing Revenue Market Forecast by Application (2024-2030)
10 Global Rare Disease Genetic Testing Forecast Market Analysis by Region
10.1 Rare Disease Genetic Testing Revenue Market Forecast by Region (2024-2030)
10.2 North America Rare Disease Genetic Testing Forecast Market Analysis
10.3 EMEA Rare Disease Genetic Testing Forecast Market Analysis
10.4 China Rare Disease Genetic Testing Forecast Market Analysis
10.5 Asia-Pacific Rare Disease Genetic Testing Forecast Market Analysis
10.6 Latin America Rare Disease Genetic Testing Forecast Market Analysis
11 Research Findings and Conclusion

List of Tables and Figures

Figure Rare Disease Genetic Testing Picture
Table Product Definition of Rare Disease Genetic Testing
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Table Global Rare Disease Genetic Testing Revenue ($) by Manufacturer (2019-2024)
Table Global Rare Disease Genetic Testing Revenue Market Share by Manufacturer (2019-2024)
Figure Global Rare Disease Genetic Testing Revenue Market Share by Manufacturer in 2024
Table Manufacturers Rare Disease Genetic Testing Production Sites, Area Served, Product Types
Table Rare Disease Genetic Testing Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2024
Table Mergers & Acquisitions, Expansion Plans
Table Global Rare Disease Genetic Testing Market Size by Type (2024 VS 2030)
Figure Global Rare Disease Genetic Testing Market Share by Type 2019 VS 2023
Table Global Rare Disease Genetic Testing Revenue and Market Size by Type (2019-2024)
Table Global Rare Disease Genetic Testing Revenue and Market Share by Type (2019-2024)
Table Global Rare Disease Genetic Testing Market Size by Application (2024 VS 2030)
Figure Global Rare Disease Genetic Testing Market Share by Application 2019 VS 2023
Table Global Rare Disease Genetic Testing Revenue Market Size by Application (2019-2024)
Table Global Rare Disease Genetic Testing Revenue Market Share by Application (2019-2024)
Figure Global Rare Disease Genetic Testing Revenue Market Size (2019-2024)
Table Rare Disease Genetic Testing Market Size by Regions: 2019 VS 2024 VS 2030
Table Rare Disease Genetic Testing Historic Revenue Market Size by Regions (2019-2024)
Table Rare Disease Genetic Testing Historic Revenue Market Share by Regions (2019-2024)
Figure North America Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Table North America Rare Disease Genetic Testing Revenue by Countries (2019-2024)
Table North America Rare Disease Genetic Testing Revenue Market Share by Countries (2019-2024)
Table North America SWOT Analysis
Figure United States Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Canada Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Table China SWOT Analysis
Figure China Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Asia Pacific Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Table Asia-Pacific Rare Disease Genetic Testing Revenue by Countries (2019-2024)
Table Asia-Pacific Rare Disease Genetic Testing Revenue Market Share by Countries (2019-2024)
Table Asia Pacific SWOT Analysis
Figure Japan Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Korea Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Southeast Asia Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure India Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Australia Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure EMEA Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Table EMEA Rare Disease Genetic Testing Revenue by Countries (2019-2024)
Table EMEA Rare Disease Genetic Testing Revenue Market Share by Countries (2019-2024)
Table EMEA SWOT Analysis
Figure Europe Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Germany Rare Disease Genetic Testing Revenue and Growth (2019-2030)
Figure France Rare Disease Genetic Testing Revenue and Growth (2019-2030)
Figure UK Rare Disease Genetic Testing Revenue and Growth (2019-2030)
Figure Italy Rare Disease Genetic Testing Revenue and Growth (2019-2030)
Figure Russia Rare Disease Genetic Testing Revenue and Growth (2019-2030)
Figure Nordic Rare Disease Genetic Testing Revenue and Growth (2019-2030)
Figure Middle East Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Africa Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Latin America Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Table Latin America Rare Disease Genetic Testing Revenue by Countries (2019-2024)
Table Latin America Rare Disease Genetic Testing Revenue Market Share by Countries (2019-2024)
Table Latin America SWOT Analysis
Figure Brazil Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Argentina Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Figure Mexico Rare Disease Genetic Testing Revenue and Growth (2019-2024)
Table Quest Diagnostics Inc. Profile
Table Product Overview
Table Quest Diagnostics Inc. Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Quest Diagnostics Inc. Revenue and Growth Rate
Figure Quest Diagnostics Inc. Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Centogene N. V Profile
Table Product Overview
Table Centogene N. V Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Centogene N. V Revenue and Growth Rate
Figure Centogene N. V Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Invitae Corp Profile
Table Product Overview
Table Invitae Corp Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Invitae Corp Revenue and Growth Rate
Figure Invitae Corp Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table 3billion, Inc. Profile
Table Product Overview
Table 3billion, Inc. Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure 3billion, Inc. Revenue and Growth Rate
Figure 3billion, Inc. Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Arup Laboratories Profile
Table Product Overview
Table Arup Laboratories Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Arup Laboratories Revenue and Growth Rate
Figure Arup Laboratories Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Eurofins Scientific Profile
Table Product Overview
Table Eurofins Scientific Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Eurofins Scientific Revenue and Growth Rate
Figure Eurofins Scientific Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Strand Life Sciences Profile
Table Product Overview
Table Strand Life Sciences Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Strand Life Sciences Revenue and Growth Rate
Figure Strand Life Sciences Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Ambry Genetics Profile
Table Product Overview
Table Ambry Genetics Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Ambry Genetics Revenue and Growth Rate
Figure Ambry Genetics Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Perkin Elmer, Inc. Profile
Table Product Overview
Table Perkin Elmer, Inc. Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Perkin Elmer, Inc. Revenue and Growth Rate
Figure Perkin Elmer, Inc. Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Realm IDX, Inc. Profile
Table Product Overview
Table Realm IDX, Inc. Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Realm IDX, Inc. Revenue and Growth Rate
Figure Realm IDX, Inc. Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Macrogen, Inc. Profile
Table Product Overview
Table Macrogen, Inc. Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2019-2024)
Figure Macrogen, Inc. Revenue and Growth Rate
Figure Macrogen, Inc. Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Labor Cost Analysis
Figure Proportion of Manufacturing Cost Structure
Figure Rare Disease Genetic Testing Industrial Chain Analysis
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Global Rare Disease Genetic Testing Revenue Market Size Forecast by Type (2024-2030)
Table Global Rare Disease Genetic Testing Revenue Market Share Forecast by Type (2024-2030)
Table Global Rare Disease Genetic Testing Revenue Market Size by Application (2024-2030)
Table Global Rare Disease Genetic Testing Revenue Market Share by Application (2024-2030)
Table Global Rare Disease Genetic Testing Revenue Market Size by Region (2024-2030)
Table Global Rare Disease Genetic Testing Revenue Market Share by Region (2024-2030)
Figure North America Rare Disease Genetic Testing Forecast Revenue and Growth 2024-2030
Figure EMEA Rare Disease Genetic Testing Forecast Revenue and Growth 2024-2030
Figure China Rare Disease Genetic Testing Forecast Revenue and Growth 2024-2030
Figure Asia-Pacific Rare Disease Genetic Testing Forecast Revenue and Growth 2024-2030
Figure Latin America Rare Disease Genetic Testing Forecast Revenue and Growth 2024-2030